Examkin

Question

Difficulty: EasySchizophrenia and Psychotic Disorders

A 28-year-old man is diagnosed with schizophrenia, and the psychiatric team is planning his long-term pharmacological management. Arrange the following interventions in the correct chronological sequence according to standard evidence-based guidelines, progressing from initial therapy to the management of highly refractory illness.

  1. 1Initiate monotherapy with a first-line antipsychotic (e.g., oral aripiprazole)
  2. 2Trial of a different first-line antipsychotic (e.g., oral risperidone)
  3. 3Initiate clozapine monotherapy
  4. 4Augment clozapine with electroconvulsive therapy (ECT) or a second agent

Answer

The correct sequence of treatment for schizophrenia is: 1) Initiate monotherapy with a first-line antipsychotic, 2) Trial a different first-line antipsychotic, 3) Initiate clozapine monotherapy, 4) Augment clozapine.
The standard pharmacological step-up therapy for schizophrenia begins with a trial of a first-line agent. If there is no response, a second trial with a different first-line agent is required. Establishing treatment-resistant schizophrenia necessitates failing two different standard antipsychotics. Once this criteria is met, clozapine is the definitive next step. Should clozapine fail to provide remission, augmentation strategies such as ECT are employed.

Step-by-Step Solution

1
Determine the appropriate initial therapy for newly diagnosed schizophrenia.
Monotherapy with a first-line antipsychotic is selected as the starting point.
Guidelines recommend starting with a single first- or second-generation antipsychotic due to their favorable efficacy-to-side-effect profile compared to clozapine.
2
Identify the next best step for a patient who fails the initial medication.
A trial of a different first-line antipsychotic is sequenced next.
Treatment-resistant schizophrenia requires the failure of two different medications, so a second standard trial must be attempted before advancing to high-risk agents.
3
Identify the criteria for initiating clozapine.
Clozapine monotherapy is sequenced after two failed antipsychotic trials.
Clozapine is highly effective but carries severe risks (e.g., agranulocytosis, myocarditis), reserving its use strictly for treatment-resistant cases.
4
Determine the management approach for clozapine non-response.
Clozapine augmentation (e.g., with ECT) is placed last in the sequence.
When a patient fails to respond adequately to clozapine, evidence supports augmentation with ECT or another pharmacological agent as a salvage therapy.

Key Concept

The step-wise pharmacological management algorithm for treatment-resistant schizophrenia.
Rate this question

Topics

Schizophrenia and Psychotic Disorders

More questions from this topic